Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) fair value: what the stock is really worth
As of Nov 10, 2026: fair value (intrinsic value) of Shanghai Aladdin Biochemical Technology Co. Ltd. A stock ¥13.72, price ¥15.05, that is 8.9% below the price, quality 62 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 11, 2026.
How to read this chart
60‑month range ¥6.33 – ¥42.86 · fair‑value band ¥9.60 – ¥17.83 · the ¥15.05 price screens above the ¥13.72 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 11, 2026.
Follow Shanghai Aladdin Biochemical Technology Co. Ltd. A in your weekly email
Every Wednesday you see whether Shanghai Aladdin Biochemical Technology Co. Ltd. A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Shanghai Aladdin Biochemical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of scientific research reagents in China and internationally.
Show moreShow less
It offers chemistry and biochemicals reagents, including blocks, ligands, catalysts, chemical synthesis, laboratory chemicals, chemical biology, analytical standards, CVD and ALD precursors, and stable isotopes; material science solutions for energy, electronic, and biomedical materials; and small molecules, such as compound libraries, ligand families, antibody-drug conjugates, and protein degradation-targeting chimeras, as well as classification by signaling pathway, target toxin, and disease.
The company also provides life sciences comprising protein, antibody, and molecular, protein, and cell biology; GMP-grade products, which include bioactive small molecules, grade protein, upstream process chemicals, downstream process and formulation chemicals, and culture medium and buffer raw materials.
In addition, it offers laboratory equipment, such as miscellaneous tools; tweezers, scrapers, and tools; PCR supplies and equipment; balance, scale, and weighing tools; sealing film, foil, and tape; filtration and chromatography; microscopes and microscope slides; liquid handling and dispensing; sample processing; glassware; and safety, gloves, eyeglasses, and cleaning products.
The company sells its reagents products under the Aladdin brand and its experimental consumables under the Core Silicon Valley brand through its e-commerce platform.
Its products are used in analytical chemistry, chemical synthesis, materials science and engineering, biopharmaceutical production, drug discovery, and genomics applications. The company was founded in 2008 and is based in Shanghai, China.
Stock analysis
Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) currently trades at ¥15.05, while our model-based Fair Value estimate is ¥13.72, so the stock looks roughly fairly valued today (gap 9.7%).
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of ¥12.27 per share, and 2 of the 26 models we run sit above the ¥15.05 price.
Bear case: the Dividend Discount group reads lowest at ¥2.03, and 24 of the 26 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ¥9.60 (bear) to ¥17.83 (bull), the price of ¥15.05 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 62/100 (solid quality), in the Basic Materials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Shanghai Aladdin Biochemical Technology Co. Ltd. A reported revenue of 696M CNY in FY2025 versus 288M CNY in FY2021, a compound +24.7%/yr. Reported net income was 102M CNY in FY2025, compounding +3.4%/yr from FY2021.
Key figures
Market cap 5.8B CNY (≈ $865M) Small · P/E ratio 33.4 · P/S ratio 9.64 · EPS (TTM) ¥0.4500 · Dividend yield 0.9% · Net margin 17.9% · Return on equity 13.5% · Return on assets (EBIT) 7.7% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 63 out of 100 (low confidence).
What moves the price
The share trades about 50% below its 52-week high and 22% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −29% fair-value upside, at −9%, 688179 screens cheaper than that median.
Fair Value models
Bear¥9.60Fair Value ¥13.72Bull¥17.83
Price ¥15.05 · Downside -8.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.2675 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF¥10.95¥16.07¥31.4376
Residual Income¥2.27¥2.49¥2.9676
Growth DCF¥10.27¥17.17¥29.9775
All 26 models by family
DCF Models
FCF DCF¥10.95¥16.07¥31.4376
Owner Earnings¥6.34¥13.17¥25.9871
5Y Revenue Exit¥4.66¥6.43¥9.9871
5Y EBITDA Exit¥5.95¥9.03¥15.0073
5Y P/E Exit¥6.03¥11.19¥17.8668
10Y Revenue Exit¥6.72¥11.02¥12.6767
10Y EBITDA Exit¥7.65¥13.58¥22.8965
10Y P/E Exit¥7.70¥13.74¥22.8361
Earnings-Based
Graham-Dodd¥1.91¥13.34¥18.7263
Lynch FV¥5.23¥7.48¥9.7261
PEG = 1.0¥5.23¥7.48¥9.7257
EPV¥2.61¥2.96¥3.2570
Dividend Discount
Gordon GGM¥1.16¥2.13¥2.9667
DDM Multi-Stage¥1.16¥1.93¥2.2767
Multiples
P/E Multiple¥3.59¥4.78¥5.9863
P/S Multiple¥1.63¥2.17¥2.7257
P/B Multiple¥3.31¥4.41¥5.5255
EV/EBIT¥4.18¥5.54¥6.9065
EV/EBITDA¥3.58¥4.74¥5.9067
EV/Revenue¥1.63¥2.28¥2.9353
Asset-Based
NCAV (Graham)¥0.3500¥0.5300¥0.660054
Growth DCF
Growth DCF¥10.27¥17.17¥29.9775
Rev-Margin DCF¥4.73¥7.36¥11.8170
Economic Profit
Residual Income¥2.27¥2.49¥2.9676
ROIC Compounder¥2.61¥3.34¥4.0671
Growth Earnings
Growth-Adj P/E¥6.13¥8.76¥11.3967
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+30.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.3%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.1%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+3.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year+2.7%
Dividend (yield on the price)0.9%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.37% → 27%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+5.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +4.0% a year for the price.
Compare Shanghai Aladdin Biochemical Technology Co. Ltd. A with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 354 stocks
Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score62 · Top 25%
Fair Value upside−8.9% · Above median
Profitability
Return on equity (12 months)13.5% · Top 25%
Return on assets5.1% · Above median
Net margin (12 months)23.7% · Top 25%
Operating margin (12 months)24.2% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)38.1% · Top 25%
Dividend yield (12 months)0.9% · Below median
Balance sheet
Debt / equity0.67× · Highest 25%
Valuation Multiplesvs Chemicals median · lower = cheaper
P/E (12 months)33.4× · Priciest 25%
P/B5.95× · Priciest 25%
P/S (12 months)9.64× · Priciest 25%
Price / free cash flow (fiscal year)21.7× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Shanghai Aladdin Biochemical Technology Co. Ltd. A Fair Value". https://www.fairvalue-calculator.com/stock/688179
Frequently asked questions
Is Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) overvalued or undervalued?
As of Nov 11, 2026, our model estimates a fair value of ¥13.72 versus a price of ¥15.05, about 9% lower (fairly valued).
What is the fair value of 688179?
Our model-based fair value for Shanghai Aladdin Biochemical Technology Co. Ltd. A is ¥13.72 (as of Nov 11, 2026), built from audited fundamentals. The current price: ¥15.05.
What is the quality score of 688179?
Shanghai Aladdin Biochemical Technology Co. Ltd. A has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
Our model-based price target is the fair value of ¥13.72 (as of Nov 11, 2026) from 26 valuation models. Cautious scenario ¥9.60, optimistic scenario ¥17.83. It is a calculation from audited fundamentals, not an analyst target.
What is the Shanghai Aladdin Biochemical Technology Co. Ltd. A stock forecast for 2026?
Our models put fair value at ¥13.72, about 9% lower versus a price of ¥15.05 (fairly valued). Cautious scenario ¥9.60, optimistic scenario ¥17.83. The calculation is refreshed regularly with new filings.
What is the revenue of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
Shanghai Aladdin Biochemical Technology Co. Ltd. A reported trailing-twelve-month revenue of about 792M CNY (latest available figure, as of Nov 11, 2026).
Does Shanghai Aladdin Biochemical Technology Co. Ltd. A pay a dividend?
Shanghai Aladdin Biochemical Technology Co. Ltd. A currently shows a dividend yield of 0.93% relative to its recent price (as of Nov 11, 2026).
How much is the dividend of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) and when is the ex-dividend date?
Shanghai Aladdin Biochemical Technology Co. Ltd. A pays a dividend of ¥0.14 per share a year, a dividend yield of 0.9%. The last ex-dividend date was Jul 2, 2026. A dividend has been paid every year since at least 2021. The payout ratio is 31.1% of earnings. Free cash flow covers the dividend 6.92 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
For today's price to be fair in a discounted-cash-flow model, Shanghai Aladdin Biochemical Technology Co. Ltd. A would have to grow free cash flow by +5.7 % per year for five years (discount rate 10.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +24.3 % per year. As of Nov 11, 2026.
What discount rate (WACC) does the fair value of 688179 use?
Our models discount Shanghai Aladdin Biochemical Technology Co. Ltd. A at 10.8 %: a base by market capitalisation (small), damped by beta 0.61, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Shanghai Aladdin Biochemical Technology Co. Ltd. A that is +5.7 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.8 %) and the same formula as our fair value.
How much growth has Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) delivered so far?
Over the past 5 years revenue at Shanghai Aladdin Biochemical Technology Co. Ltd. A grew +24.3 % a year. The price currently implies free-cash-flow growth of +5.7 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) growing?
The median revenue growth in the sector is +8.7 % a year. That is the yardstick for the growth priced into Shanghai Aladdin Biochemical Technology Co. Ltd. A (+5.7 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
The free-cash-flow yield on the price is 7.02 %: that much free cash flow Shanghai Aladdin Biochemical Technology Co. Ltd. A produces per unit of market value. When it exceeds the discount rate of our models (10.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Shanghai Aladdin Biochemical Technology Co. Ltd. A it is ¥13.72 per share (as of Nov 11, 2026), against a price of ¥15.05. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Shanghai Aladdin Biochemical Technology Co. Ltd. A stock overvalued or undervalued in 2026?
As of Nov 11, 2026, 688179 trades above its calculated fair value: price ¥15.05, fair value ¥13.72, a gap of about −9% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 688179?
No. The price is what the market pays today (¥15.05); the fair value is what the company's own numbers justify (¥13.72). For Shanghai Aladdin Biochemical Technology Co. Ltd. A the two are ¥1.33 per share apart. That gap is exactly why we show both numbers side by side.
How much is Shanghai Aladdin Biochemical Technology Co. Ltd. A worth?
The market values Shanghai Aladdin Biochemical Technology Co. Ltd. A at about 5.8B CNY (market capitalisation, as of Nov 11, 2026). Per share that is ¥15.05; our models calculate a fair value of ¥13.72 per share.
What do the bullish and bearish scenarios say about 688179?
Our models span a range for Shanghai Aladdin Biochemical Technology Co. Ltd. A: cautious scenario ¥9.60, base ¥13.72, optimistic ¥17.83 per share (as of Nov 11, 2026, price ¥15.05). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 688179?
Shanghai Aladdin Biochemical Technology Co. Ltd. A trades at a price-to-earnings ratio of 33.4 (as of Nov 11, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥13.72 is built from several models across several years. Other multiples: P/B 6.0, P/S 9.6, EV/EBITDA 32.9.
How solid is the balance sheet of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
Balance-sheet figures for Shanghai Aladdin Biochemical Technology Co. Ltd. A (as of Nov 11, 2026): return on equity 13.5%, debt of 0.67 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is 688179 from its 52-week high?
Shanghai Aladdin Biochemical Technology Co. Ltd. A trades at ¥15.05, about 50% below its 52-week high of ¥30.14 and 22% above the low of ¥12.36 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of ¥13.72 is for.
Which stocks are comparable to Shanghai Aladdin Biochemical Technology Co. Ltd. A?
From the same area (Basic Materials) we also value BASF SE, Dow Inc, Ningxia Baofeng Energy Group, Rongsheng Petrochemical Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Shanghai Aladdin Biochemical Technology Co. Ltd. A stock attractive at the current price?
The data as of Nov 11, 2026: price ¥15.05, calculated fair value ¥13.72 (−9%), Quality Score 62/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 688179 calculated?
We run Shanghai Aladdin Biochemical Technology Co. Ltd. A through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥13.72 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Shanghai Aladdin Biochemical Technology Co. Ltd. A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
The closing price on Nov 10, 2026 was ¥15.05. Our model-based fair value is ¥13.72, about 9% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Shanghai Aladdin Biochemical Technology Co. Ltd. A right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (¥9.60 to ¥17.83) leaves room in how you read the outcome.
Key figures of Shanghai Aladdin Biochemical Technology Co. Ltd. A
How large is the market capitalisation of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
The market capitalisation of Shanghai Aladdin Biochemical Technology Co. Ltd. A is 5.8B CNY (≈ $865M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
The price-to-sales ratio of Shanghai Aladdin Biochemical Technology Co. Ltd. A is 9.64 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
Earnings per share at Shanghai Aladdin Biochemical Technology Co. Ltd. A are ¥0.4500 (price ÷ EPS = P/E 33.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
The dividend yield of Shanghai Aladdin Biochemical Technology Co. Ltd. A is 0.9% (payout 31.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
The net margin of Shanghai Aladdin Biochemical Technology Co. Ltd. A is 17.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
The return on equity (ROE) of Shanghai Aladdin Biochemical Technology Co. Ltd. A is 13.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
On an EBIT basis the return on assets of Shanghai Aladdin Biochemical Technology Co. Ltd. A is 7.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
The operating margin of Shanghai Aladdin Biochemical Technology Co. Ltd. A is 24.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
Revenue at Shanghai Aladdin Biochemical Technology Co. Ltd. A is growing +38.1% versus a year earlier (3y avg +22.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179)?
Earnings per share at Shanghai Aladdin Biochemical Technology Co. Ltd. A are growing +632% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Shanghai Aladdin Biochemical Technology Co. Ltd. A in the live analysis
One click puts Shanghai Aladdin Biochemical Technology Co. Ltd. A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 11, 2026